ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
Trial details
- Registry ID
- NCT07011706
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisNCT07011706 | ACRS | Phase 2 | Active not recruiting | 2026-09-21Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |